Relationships between β-amyloid and tau in an elderly population: An accelerated failure time modelww
Terry M. Therneau, Ph.D.,
David S. Knopman, M.D.,
Val J. Lowe, M.D.,
Hugo Botha, M.B., Ch.B.,
Jonathan Graff-Radford, M.D.,
David T. Jones, M.D.,
Prashanthi Vemuri, Ph.D.,
Michelle M. Mielke, Ph.D.,
Christopher G. Schwarz, Ph.D.,
Matthew L. Senjem, M.S.,
Jeffrey L. Gunter, Ph.D.,
Ronald C. Petersen, M.D., Ph.D.,
Clifford R. Jack, Jr, M.D.
Affiliations
Terry M. Therneau, Ph.D.
Department of Quantitative Health Sciences, Mayo Clinic 200 1st St. SW, Rochester, MN 55905; Corresponding author.
David S. Knopman, M.D.
Department of Neurology, Mayo Clinic 200 1st St. SW, Rochester, MN 55905
Val J. Lowe, M.D.
Department of Radiology, Mayo Clinic 200 1st St. SW, Rochester, MN 55905
Hugo Botha, M.B., Ch.B.
Department of Neurology, Mayo Clinic 200 1st St. SW, Rochester, MN 55905
Jonathan Graff-Radford, M.D.
Department of Neurology, Mayo Clinic 200 1st St. SW, Rochester, MN 55905
David T. Jones, M.D.
Department of Neurology, Mayo Clinic 200 1st St. SW, Rochester, MN 55905
Prashanthi Vemuri, Ph.D.
Department of Radiology, Mayo Clinic 200 1st St. SW, Rochester, MN 55905
Michelle M. Mielke, Ph.D.
Department of Quantitative Health Sciences, Mayo Clinic 200 1st St. SW, Rochester, MN 55905; Department of Neurology, Mayo Clinic 200 1st St. SW, Rochester, MN 55905
Christopher G. Schwarz, Ph.D.
Department of Radiology, Mayo Clinic 200 1st St. SW, Rochester, MN 55905
Matthew L. Senjem, M.S.
Department of Informational Technology, Mayo Clinic 200 1st St. SW, Rochester, MN 55905
Jeffrey L. Gunter, Ph.D.
Department of Radiology, Mayo Clinic 200 1st St. SW, Rochester, MN 55905
Ronald C. Petersen, M.D., Ph.D.
Department of Quantitative Health Sciences, Mayo Clinic 200 1st St. SW, Rochester, MN 55905; Department of Neurology, Mayo Clinic 200 1st St. SW, Rochester, MN 55905
Clifford R. Jack, Jr, M.D.
Department of Radiology, Mayo Clinic 200 1st St. SW, Rochester, MN 55905
Using positron emission tomography (PET)-derived amyloid and tau measurements from 1,495 participants, we explore the evolution of these values over time via an accelerated failure time (AFT) model. The AFT model assumes a shared pattern of progression, but one which is shifted earlier or later in time for each individual; an individual's time shift for amyloid and for tau are assumed to be linked. The resulting pattern for each outcome consists of an earlier indolent phase followed by sharp progression of the accumulation rate. APOE ε4 shifts the amyloid curve leftward (earlier) by 6.1 years, and the tau curve leftward by 2.6 years. Female sex shifts the amyloid curve leftward by 2.4 years and the tau curve leftward by 2.6 years. Per-person shifts (i.e., the individual's deviation from the population mean) for the onset of amyloid accumulation ranged from 13 years earlier to 13 years later (10th to 90th percentile) than average and 11 years earlier to 14 years later for tau, with an estimated correlation of 0.49. The average delay between amyloid increase and tau increase was 13.3 years.